###begin article-title 0
A Novel Role for PECAM-1 (CD31) in Regulating Haematopoietic Progenitor Cell Compartmentalization between the Peripheral Blood and Bone Marrow
###end article-title 0
###begin p 1
Conceived and designed the experiments: GN SE CB ER SF TD SW JF. Performed the experiments: ER YZ TD ER SL ZA TH NK. Analyzed the data: CB ER SF ZA TH NK. Contributed reagents/materials/analysis tools: SE. Wrote the paper: GN CB ER SF SW JF.
###end p 1
###begin p 2
###xml 391 394 391 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 945 948 945 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
Although the expression of PECAM-1 (CD31) on vascular and haematopoietic cells within the bone marrow microenvironment has been recognized for some time, its physiological role within this niche remains unexplored. In this study we show that PECAM-1 influences steady state hematopoietic stem cell (HSC) progenitor numbers in the peripheral blood but not the bone marrow compartment. PECAM-1-/- mice have higher levels of HSC progenitors in the blood compared to their littermate controls. We show that PECAM-1 is required on both progenitors and bone marrow vascular cells in order for efficient transition between the blood and bone marrow to occur. We have identified key roles for PECAM-1 in both the regulation of HSC migration to the chemokine CXCL12, as well as maintaining levels of the matrix degrading enzyme MMP-9 in the bone marrow vascular niche. Using intravital microscopy and adoptive transfer of either wild type (WT) or PECAM-1-/- bone marrow precursors, we demonstrate that the increase in HSC progenitors in the blood is due in part to a reduced ability to migrate from blood to the bone marrow vascular niche. These findings suggest a novel role for PECAM-1 as a regulator of resting homeostatic progenitor cell numbers in the blood
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 301 304 301 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Wagers1">[1]</xref>
###xml 306 309 306 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Heissig1">[2]</xref>
###xml 464 467 460 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Wright1">[3]</xref>
###xml 621 624 617 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Broxmeyer1">[4]</xref>
###xml 625 628 621 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Peled1">[7]</xref>
###xml 741 744 737 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Sugiyama1">[8]</xref>
The bi-directional movement of HSCs between the vascular niche and the circulation is an area of intense study. Alterations in integrins, chemokine receptors and the activation of proteases have all been demonstrated to be required for HSC mobilization and subsequent engraftment to occur efficiently [1], [2] Of particular importance is the localised concentration of CXCL12 (SDF-1alpha) in the bone marrow as this is the principal chemokine to which HSCs respond[3]. This chemokine not only acts as a chemoattractant for HSCs, but ligation of its receptor, CXCR4, induces integrin upregulation and promotes HSC survival[4]-[7]. Modulation of the CXCR4/CXCL12 interaction on HSCs has been shown to directly affect HSC migration and function[8].
###end p 4
###begin p 5
###xml 195 198 195 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Newman1">[9]</xref>
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Slieker1">[10]</xref>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-deBruijn1">[12]</xref>
###xml 523 524 523 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 544 548 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Ling1">[13]</xref>
###xml 582 586 582 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Ling1">[13]</xref>
###xml 588 592 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Lee1">[14]</xref>
###xml 627 628 627 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 725 729 725 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Ferrero1">[15]</xref>
###xml 731 735 731 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Bird1">[16]</xref>
###xml 795 799 795 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Leavesley1">[17]</xref>
###xml 871 875 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Yong1">[18]</xref>
###xml 877 881 877 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Voermans1">[19]</xref>
Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1/CD31) is a 130kDa glycoprotein and member of the immunoglobulin superfamily, which is expressed on many haematopoietic and endothelial cells[9]. PECAM-1 is expressed on the surface of various cells of the haematopoietic lineage[10]-[12], however the function of PECAM-1, if any, on haematopoietic progenitor cells and the bone marrow vasculature remains to be fully elucidated. It has been observed that expression of PECAM-1 decreases following the emigration of CD34+ cells and monocytes[13] from the bone marrow to the blood[13], [14]. The expression of PECAM-1 on CD34+ cells, like that on endothelial cells, has been demonstrated to provide an anti-apoptotic signal[15], [16], with ligation of PECAM-1 enhancing VLA-4 mediated adhesion[17], and blocking antibodies to PECAM-1 reducing transendothelial migration[18], [19].
###end p 5
###begin p 6
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Dhanjal1">[20]</xref>
###xml 161 165 161 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Wu1">[21]</xref>
We and others have recently discovered a novel role for PECAM-1 in regulating CXCR4 dependent megakaryocyte migration within the bone marrow vascular niche[20], [21]. The expression of PECAM-1 on HSCs and the bone marrow vasculature, together with the well established role for PECAM-1 in regulating cell adhesion, migration and activation in cells of haematopoietic origin prompted us to examine whether PECAM-1 could regulate HSC function in the bone marrow vascular niche.
###end p 6
###begin p 7
###xml 140 143 140 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 675 678 675 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 848 851 848 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
###xml 852 856 <span type="species:ncbi:10090">mice</span>
We observed that PECAM-1 regulates steady state progenitor cell numbers in the peripheral blood but not the bone marrow compartment. PECAM-1-/- mice exhibited an increase in the number of circulating progenitor cells in the resting state, compared to littermate wild type control mice. Using intra-vital microscopy, we found that loss of PECAM-1 on either bone marrow progenitors or vascular cells resulted in the failure of cells to migrate across the bone marrow vasculature leading to their accumulation within the peripheral circulation. We have identified an intrinsic migration defect of HSCs to CXCL12 as well as increased levels of MMP-9 in the bone marrow of PECAM-1-/- mice, suggesting that factors intrinsic to both the HSC and bone marrow vascular niche account for the increase in circulating progenitor numbers in the blood of PECAM-1-/- mice.
###end p 7
###begin p 8
Our results suggest that PECAM-1 plays an important role in integrating CXCL12 dependent signals involved in HSC accumulation within the bone marrow, such that loss of PECAM-1 prevents effective bidirectional movement of HSCs between the blood and bone marrow compartments.
###end p 8
###begin title 9
Materials and Methods
###end title 9
###begin title 10
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice and bone marrow collection
###end title 10
###begin p 11
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 367 368 367 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 381 382 381 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 393 394 393 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 316 320 <span type="species:ncbi:10090">mice</span>
Age and sex matched wild type (WT) and PECAM-1-/- littermates on the C57BL6J background were bred from heterozygotes. All mice were maintained at the Biomedical services unit at the University of Birmingham, according to Home Office regulations. Bone marrow cells were flushed from femurs and tibias of 6-9 week old mice, and resuspended in ACK lysis buffer (0.15M NH4Cl; 1 mM KHCO3; 0.1 mM Na2EDTA pH7.3) to lyse mature erythrocytes before use in subsequent assays.
###end p 11
###begin title 12
Flow Cytometric Analysis
###end title 12
###begin p 13
###xml 678 679 678 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 686 687 686 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 699 700 699 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 736 737 736 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 161 166 <span type="species:ncbi:10090">mouse</span>
Bone marrow cell populations were quantified and phenotyped using a CyAn ADP flow cytometer (Dako, Ely, UK). The following monoclonal antibodies were used: anti-mouse lineage panel-APC, anti-c-Kit-RPE, anti-Sca-1-PE/Cy7, anti-CD127-Pacific Blue (all BD Biosciences), anti-CD34-FITC, anti-CD16/CD32-PE/Cy5 and biotinylated anti-CD135 (all eBioscience, Insight Biotechnology, UK). Biotinylated antibodies were visualised with streptavidin-APC/Cy7 (BD Bioscience). Chemokine receptor and integrin expression was demonstrated using biotinylated anti-CXCR4, anti-CD49d or FITC labelled anti-CD18, CD29 and CD61 antibodies (all BD Biosciences). The HSC population was defined as c-Kit+, Sca-1+ but lineage- (KSL population), and at least 1x106 total bone marrow events were analysed per sample . KSL cells were purified by double FACS sorting using a high speed cell sorter (Dako, Ely, UK).
###end p 13
###begin title 14
Cell Migration Assays
###end title 14
###begin p 15
###xml 349 350 345 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 212 218 <span type="species:ncbi:10090">murine</span>
Transwell chamber assays were performed in transwell buffer (RPMI supplemented with 2 mM glutamine, 100units/ml penicillin, 100 microg/ml streptomycin and 0.5% Fraction V BSA; all Sigma-Aldrich, UK). Recombinant murine CXCL12 (Peprotech EC, UK) was added to the bottom chamber at 200-500 ng/ml. Cell suspensions were isolated and resuspended at 2x106/ml in transwell buffer, before adding 100 microl to the top chamber. Assays ran for 4 hours before collecting and quantifying the cells migrated into the bottom chamber using a fixed volume count flow cytometry protocol (Epics XL, Coulter). PI was added to each tube to discriminate dead cells and debris.
###end p 15
###begin p 16
###xml 709 713 705 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Dhanjal1">[20]</xref>
###xml 715 719 711 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Zicha1">[22]</xref>
###xml 731 732 727 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Dunn chamber assays were performed using HSCs purified by immunomagnetic bead selection. Whole bone marrow was firstly negatively depleted with lineage specific beads (Lineage Cell Depletion Kit, Miltenyi Biotech) according to the manufacturer's instructions. The resulting cells were then positively selected using CD117 Microbeads (Miltenyi Biotech) and rested overnight in StemCell Pro media (supplemented with 2.6% serum replacement, 2 mM glutamine, 100 units/ml penicillin, 100 microg/ml streptomycin), and containing factors to promote survival and inhibit differentiation (50 ng/ml recombinant SCF and 10 ng/ml recombinant Flt-3L; Peprotech EC, UK). Dunn chambers were performed as previously described[20], [22], using 2x105 cells per assay.
###end p 16
###begin title 17
G-CSF Induced CFC Mobilisation
###end title 17
###begin p 18
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 101 105 101 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Petit1">[23]</xref>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
The induced mobilisation of bone marrow HSCs was performed using a protocol adapted from Petit et al.[23]. Briefly, mice received a daily subcutaneous injection of G-CSF (Neupogen, Amgen Inc, USA; 300 microg/kg in 100 microl PBS) for 4 consecutive days and were sacrificed 6 hours after the last injection. Peripheral blood was collected by cardiac puncture into heparinised tubes, and leg bones removed. The quantification of CFCs in bone marrow and peripheral blood was performed using MethoCult GF media (M3434, Stemcell Technologies, UK), according to the manufacturers protocol. Two independent researchers counted all colonies on duplicate plates for each condition tested at days 7 and 10.
###end p 18
###begin title 19
CXCL12 ELISA
###end title 19
###begin p 20
###xml 258 264 248 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 264 268 254 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Petit1">[23]</xref>
###xml 460 461 442 443 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 463 464 445 446 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 477 478 459 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1170 1171 1132 1133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1173 1174 1135 1136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
###xml 691 697 <span type="species:ncbi:10090">murine</span>
CXCL12 levels in bone marrow were measured by flushing the femurs and tibias from one mouse with 500 microls of PBS. Cells were centrifuged, supernatants aliquoted and frozen at -80degreesC. ELISAs were performed according to the protocol published by Petit et al.[23]. Briefly, wells of a 96-well plate were coated overnight with 50 microls of anti-CXCL12 antibody (MAb 79018, R&D Systems, UK) at a concentration of 2 microg/ml in bicarbonate buffer (15 mM Na2CO3; 35 mM NaHCO3 pH9.6). Wells were washed 3 times, blocked for 1 hour with PBS/1%BSA/5% Sucrose at room temperature, rewashed 3 times and 50 microl of sample in duplicate wells added for 2 hours at room temperature. Recombinant murine CXCL12 (Peprotech EC) was used to generate a standard curve. Wells were washed 3 times and 50 microls of anti-CXCL12-biotin capture antibody (MAb BAF310, R&D Systems, UK) at 250 ng/ml for 2 hours at room temperature. After 3 washes, 50 microl of streptavidin-HRP was added for 20 mins at room temperature, washed for a further 3 times, and incubated for 20-30 mins with 50 microl of TMB substrate solution (Sigma-Aldrich, UK). Reactions were stopped with 50 microl of 2M H2SO4 and wells read at 450 nm on an optical plate reader. All samples analysed were quantified for protein concentration and results expressed as ng/ml CXCL12 per mg/ml protein in solution.
###end p 20
###begin title 21
Indirect Immunofluorescence staining and confocal microscopy
###end title 21
###begin p 22
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
###xml 94 98 <span type="species:ncbi:9925">goat</span>
###xml 365 369 <span type="species:ncbi:9925">goat</span>
###xml 375 380 <span type="species:ncbi:10090">mouse</span>
Cryosections (8 microm) of mouse femur were fixed in acetone and blocked with 5% mouse and 5% goat serum in PBS. Sections were stained with the following antibodies: From Ebioscience anti-endoglin-biotin (clone MJ7/18) and anti-VCAM-1-FITC (clone 429). Anti-CXCL12 (clone 79018) was from R&D Systems. Secondary reagents were anti-FITC-Alexa 488 (Molecular Probes), goat anti-mouse IgG1-TRITC (Southern Biotech) and Streptavidin-Cy5 (Jackson Immuno Research). Cell nuclei were visualised using Hoescht 33258. A Zeiss confocal LSM 510 microscope (Zeiss, Germany) was used to visualize staining with images captured and processed using the Zeiss LSM Image Examiner software (Zeiss).
###end p 22
###begin title 23
Intravital Imaging of the Bone Marrow Microcirculation
###end title 23
###begin p 24
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Mazo1">[24]</xref>
Intravital observations of the bone marrow were made using the skull window preparation previously described by Mazo and colleagues[24]. All procedures were undertaken with United Kingdom Home Office approval in accordance with the Animals (Scientific Procedures) Act of 1986 (Project Licence No: 40/2749). Anaesthesia was induced with an intraperitoneal injection ketamine (100 mg/kg Vetalar; Pharmacia and Upjohn Ltd, UK) and 2% xylazine (20 mg/kg; Millpledge Pharamaceuticals, UK). Cannulae were inserted in the trachea to facilitate spontaneous respiration and in the left carotid artery to provide a route for administration of additional anaesthesia as required. The carotid cannula also provided access for administration of fluorescently labelled albumin and cells. The scalp was incised in the midline and the frontoparietal skull was exposed carefully avoiding tissue damage to the area. A plastic ring was placed to maintain exposure of the incision and to allow application of sterile saline to prevent drying of the tissue. The animal was immobilised in a custom made stereotactic frame.
###end p 24
###begin p 25
Animals were transferred to the stage of a motorized Olympus BX-61WI microscope equipped with a water immersion objective (Olympus UmplanFI 10x/0.30w). The microvessels were identified after administration of FITC-BSA (0.1 mg/ml, Sigma, UK). Following this, whole bone marrow cells were isolated from femurs as previously described, labelled with 5 microM CFSE (Molecular Probes, Invitrogen, Paisley, UK) and introduced systematically. Digital images were collected using a high capture rate Sensicam CCD camera (the Cooke Corporation, USA). A high performance GEN III image intensifier (Videoscope Int. Ltd., USA) incorporated between the microscope and camera amplified light 1000-fold, allowing visualization of low fluorescent intensities. Images were collected using Slidebook software (Intelligent Imaging Innovations, USA) and stored as permanent digital images for subsequent off line analysis. One pre-selected field of view was recorded for 5 mins after administration of bone marrow cells to allow quantification of rolling cells. To quantify adherent cells, a second recording of the entire exposed left frontoparietal area was captured one hour post-injection. Cells adherent to the microvessels for <30 seconds were considered adherent.
###end p 25
###begin title 26
Zymography
###end title 26
###begin p 27
###xml 712 716 698 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Ahmed1">[25]</xref>
Bone marrow flushes were spun down to remove cell debris and quantified for protein content by BCA assay (Pierce, UK). 20 microg total protein was prepared in nondenaturing loading buffer and size fractionated in 10% SDS-polyacrylamide gel containing 1 mg/ml collagen. Gels were washed twice in 2.5% Triton X-100 and incubated overnight at 37degreesC in 10 mM Tris-HCl buffer, pH 7.5 containing 1.25% Triton X-100, 5 mM calcium chloride and 1 microM zinc chloride. Gels were fixed in 50% methanol and 10% acetic acid containing 0.25% Coomassie Blue for 2 hours, and the digested bands revealed by destaining with 25% methanol and 10% acetic acid solution. Gels were scanned and quantified as previously described[25].
###end p 27
###begin title 28
Statistical Analysis
###end title 28
###begin p 29
###xml 215 216 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 245 246 243 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
All experiments were performed a minimum of three times and images shown are representative of one experiment performed. Data are shown as mean+/-S.D. and statistical analysis was performed using 2-tailed Student's t test. Probability values of P below 0.05 were considered to be statistically significant.
###end p 29
###begin title 30
Results
###end title 30
###begin title 31
###xml 84 87 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
Phenotypic analysis of HSC numbers and differentiation in the bone marrow of PECAM-1-/- mice
###end title 31
###begin p 32
###xml 232 235 232 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 242 251 242 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002338-g001">Figure 1A</xref>
###xml 435 444 431 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002338-g001">Figure 1B</xref>
###xml 508 512 504 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Goodell1">[26]</xref>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
We first examined HSC cell numbers in the bone marrow of PECAM-1 deficient mice compared to age and sex matched littermate controls. Total bone marrow cell numbers were the same in bone marrow flushes from WT littermates and PECAM-1-/- mice (Figure 1A). The number of HSCs, defined by KSL staining, in PECAM-1 deficient mice was not significantly different compared to WT littermate controls (WT 0.16%+/-0.14, KO 0.21%+/-0.2, n = 21) (Figure 1B). A similar observation was made using side population analysis[26] (data not shown). This suggests that bone marrow cell homeostasis is maintained upon PECAM-1 deletion.
###end p 32
###begin title 33
Analysis of haematopoietic progenitors in the bone marrow and peripheral blood.
###end title 33
###begin p 34
###xml 89 92 89 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 598 601 596 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 546 550 <span type="species:ncbi:10090">mice</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
(A) There was no significant difference in total bone marrow cell numbers between PECAM-1-/- and WT mice (n = 21). (B) The percentage of KSL cells in the bone marrow cellular pool was measured by flow cytometry, and no significant difference was observed (n = 22 pairs). Bars in (A) and (B) represent mean values, and in both cases no significant difference was observed. (C) The number of colony forming cells (CFCs) in peripheral blood of mice was determined using methylcellulose assays. Data shown is the mean+/-S.D. of 6 pairs of littermate mice, **p = 0.008. To measure the ability of PECAM-1-/- HSCs to mobilise from the bone marrow, mice were treated with a daily injection of G-CSF. No significant difference in the number of CFCs released into the peripheral blood was found. (n = 6 pairs of littermates).
###end p 34
###begin p 35
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Akashi1">[27]</xref>
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Christensen1">[29]</xref>
###xml 153 160 153 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002338-t001">Table 1</xref>
###xml 294 297 294 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 572 576 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Kiel1">[30]</xref>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
We next examined whether there were differences in progenitor subsets in the bone marrow based on previously published phenotyping information[27]-[29]. Table 1 shows there were no significant differences in the numbers of the commonly described subsets of HSC progenitors in the WT and PECAM-1-/-, mice suggesting that loss of PECAM-1 does not drive differentiation into one particular haematopoietic lineage. Similar findings were observed using the recently described protocols to differentiate HSCs based on their expression of the SLAM family receptors CD48 and CD150[30] (data not shown).
###end p 35
###begin title 36
Flow cytometric analysis of haematopoietic progenitor subsets.
###end title 36
###begin p 37
###xml 187 193 187 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LT-HSC</italic>
###xml 209 215 209 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST-HSC</italic>
###xml 232 235 232 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MPP</italic>
###xml 260 263 260 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLP</italic>
###xml 292 295 292 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMP</italic>
###xml 323 326 323 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GMP</italic>
###xml 354 357 354 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEP</italic>
###xml 445 448 445 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
Bone marrow cells were isolated and subgroups of haematopoietic progenitor cells were identified by flow cytometry from 6-8 week old mice. Data shown is from at least 6 littermate pairs. LT-HSC Long-Term HSC; ST-HSC Short-Term HSC; MPP Multipotent Progenitor; CLP Common Lymphoid Progenitor; CMP Common Myeloid Progenitor; GMP Myelomonocytic Progenitor; MEP Megakaryocytic/Erythrocyte Progenitor. No significant difference between WT and PECAM-1-/- mice was observed in any of the populations studied.
###end p 37
###begin title 38
###xml 91 94 91 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
Increased numbers of functional progenitor cells in the steady state circulation of PECAM-1-/- mice
###end title 38
###begin p 39
###xml 140 149 140 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002338-g001">Figure 1C</xref>
###xml 232 235 232 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 416 425 416 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002338-g001">Figure 1C</xref>
###xml 499 502 499 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 503 507 <span type="species:ncbi:10090">mice</span>
We next examined whether loss of PECAM-1 affected the accumulation of HSC progenitors in the peripheral blood, using colony forming assays (Figure 1C). We observed a significant increase in the number of CFCs in the blood of PECAM-1-/- mice in steady state conditions compared to WT littermate controls. Following enforced mobilization with G-CSF there were no differences in either the number of CFCs in the blood (Figure 1C) or the percentage of KSL cells in the bone marrow in both WT and PECAM-1-/- mice (data not shown), suggesting that loss of PECAM-1 selectively affects progenitor cells numbers in the steady state circulation, but does not affect their ability to be actively mobilized.
###end p 39
###begin title 40
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
PECAM-1-/- HSC cells demonstrate impaired migration to CXCL12 (SDF-1alpha)
###end title 40
###begin p 41
###xml 188 191 184 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Hattori1">[5]</xref>
###xml 247 250 243 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 451 454 445 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 551 560 545 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002338-g002">Figure 2A</xref>
###xml 670 671 664 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 784 787 778 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1061 1064 1055 1058 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1163 1166 1157 1160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
CXCL12 (SDF-1alpha) is critically involved in the regulation of HSC accumulation and migration, both within the bone marrow niche and between the bone marrow and the peripheral circulation[5]. We therefore examined the ability of HSCs from PECAM-1-/- and littermate controls to migrate to CXCL12. Purified KSL cells were isolated from whole bone marrow by cell sorting (>/=99% purity), and migration to CXCL12 assessed using a Transwell assay. PECAM-1-/- KSL cells displayed a reduced capacity to migrate to CXCL12 compared to WT littermate controls (Figure 2A). A similar effect was observed using whole bone marrow extracts, isolated thymocytes and purified mature CD3+ splenic T cells suggesting that the altered migration response to CXCL12 is an intrinsic property of the PECAM-1-/- HSCs, and that the defect persists throughout haematopoietic development in lymphocytes. Whole bone marrow cell preparations were also assayed using other chemotactic agents including MCP-1, KC, RANTES and IL-8, but no difference in the migratory capacity of WT and PECAM-1-/- was observed to these chemotactic agents (data not shown). Thus the defect in migration of PECAM-1-/- bone marrow cells appears to be specific to CXCL12.
###end p 41
###begin title 42
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
PECAM-1-/- HSCs demonstrate defective cell migration towards a gradient of CXCL12.
###end title 42
###begin p 43
###xml 24 25 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 64 67 52 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 356 357 344 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 484 485 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1152 1155 1132 1135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
(A) 0.1approximately1x106 cells isolated from individual PECAM-1-/- and littermate matched WT animals were placed in a transwell chamber and their ability to migrate to a gradient of CXCL12 was quantified from at least 3 pairs of mice; cell sorted KSLs (n = 3, p = 0.019), whole bone marrow (n = 7, p = 0.02), thymocytes (n = 4, p = 0.005) and purified CD3+ T cells (n = 7, p = 0.03). (B) Dunn chambers were used to trace the migration path over one hour of 20 lineage depleted, CD117+ progenitor cells. The intersection of the x- and y-axis was taken as the starting point of each cell path, and the source of CXCL12 was at the top. Circular histograms show the proportion of cells whose final position was located within each of 18 equal sectors (20degrees). (C) The net translocation distance (displacement from start to end point) of each cell was measured (mean+/-S.D.; *p>0.05). (D) Expression levels of surface proteins on KSL cells were quantified on whole bone marrow isolates by flow cytometry. Histograms I-VI are representative of at least four independent experiments, and no significant difference in staining was observed between PECAM-1-/- (grey) and WT (black) littermate controls, except for CD29 (ii, n = 5, *p = 0.038). Faint histograms depict the appropriate isotype controls.
###end p 43
###begin p 44
###xml 172 173 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 284 288 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Nilsson1">[31]</xref>
###xml 365 374 365 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002338-g002">Figure 2B</xref>
###xml 510 513 510 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 645 648 645 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 659 663 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Dhanjal1">[20]</xref>
###xml 766 769 760 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 775 776 769 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 835 838 829 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 960 969 954 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002338-g002">Figure 2C</xref>
These findings using static transwell assays were confirmed using Dunn chamber migration assays to assess the speed and direction of cell migration. Lineage negative, CD117+ progenitor cells were allowed to migrate on fibronectin, a major extracellular matrix component of bone marrow[31], to a gradient of CXCL12. Individual line tracings and circular histograms (Figure 2B) show the overall speed and direction of migration, and demonstrates the variation in the rate of movement of individual cells. PECAM-1-/- cells exhibited a more random migratory pattern consistent with loss of CXCR4 polarisation which has been observed in other PECAM-1-/- cell types[20]. 88% of WT cells move to within a 120degrees arc facing the CXCL12 source, whereas only 52% of PECAM-1-/- CD117+ cells do so. The cell traces also demonstrate that PECAM-1-/- cells move relatively short distances before changing direction, suggesting that they also lack directional persistence (Figure 2C).
###end p 44
###begin p 45
###xml 62 65 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 258 267 258 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002338-g002">Figure 2D</xref>
###xml 372 375 372 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 438 441 438 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 592 595 589 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 722 726 719 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Lenter1">[32]</xref>
###xml 728 732 725 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Bazzoni1">[33]</xref>
###xml 777 780 774 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
To determine if the reduced migration to CXCL12 in the PECAM-1-/- HSCs was due to altered expression of cell surface receptors on the HSCs, key molecules involved in migration to CXCL12 and in migration on cell matrices were quantified using flow cytometry (Figure 2D). Importantly, the expression of CXCR4 and a range of integrin receptors were the same on WT and PECAM-1-/- HSC, suggesting that the reduced response to CXCL12 by PECAM-1-/- HSCs is an intrinsic defect, and not due lack of expression of the CXCR4 receptor. Despite the slightly increased beta1 integrin expression on PECAM-1-/- cells, this integrin is in the normal activation state as shown by expression of the activation epitope specific antibody 9EG7[32], [33]. Thus the defect in migration of the PECAM-1-/- does not appear to be due to inappropriate activation of beta1 integrins following PECAM-1 deletion.
###end p 45
###begin title 46
###xml 106 109 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
Normal expression of CXCL12, but increased MMP-9 expression in the bone marrow microenvironment in PECAM-1-/- mice
###end title 46
###begin p 47
###xml 269 272 269 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 381 390 381 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002338-g003">Figure 3A</xref>
###xml 455 458 455 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 691 695 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Nakamura1">[34]</xref>
###xml 753 756 753 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 764 768 <span type="species:ncbi:10090">mice</span>
PECAM-1 is expressed not only on cells of the haematopoietic lineage but also on blood vessels in the bone marrow. This raised the possibility that factors intrinsic to bone marrow vascular cells might also contribute to the increase HSC numbers in the blood of PECAM-1-/- mice. To address this question, total levels of CXCL12 present in the bone marrow were quantified by ELISA (Figure 3A). CXCL12 levels were not statistically different between PECAM-1-/- and WT littermates, suggesting that the increased number of CFCs in the blood is unlikely to be due to loss of CXCL12 in the bone marrow. Levels of stem cell factor (SCF), another important factor in HSC release into the circulation[34] were also measured and these were similar between PECAM-1-/- and WT mice (data not shown).
###end p 47
###begin title 48
###xml 18 21 18 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Effects of PECAM-1-/- deletion on the bone marrow microenvironment.
###end title 48
###begin p 49
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 129 132 129 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 314 317 314 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 660 663 660 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 271 277 <span type="species:ncbi:10090">murine</span>
PECAM-1-/- and WT littermate bone marrow was collected in PBS and analysed for factors important in HSC mobilisation. (A) PECAM-1-/- bone marrow has comparable levels of CXCL12 compared to WT littermates, as measured by ELISA (n = 13). (B) Longitudinal sections of whole murine femora from matched pairs of PECAM-1-/- and WT littermates were immunofluorescently stained for components of the bone marrow microenvironment; CXCL12 (red), VCAM-1 (green) and marrow sinusoidal vessels by endoglin (CD105, blue). Images are representative of at least three pairs of femurs, and images are taken at x40 magnification. (C.) In-gel zymography demonstrated that PECAM-1-/- bone marrow flushes contained higher levels of MMP-9. Pooled data from 6 litter matched pairs confirmed this to be a significant difference (data shown as the mean+/-S.D., *p = 0.003).
###end p 49
###begin p 50
###xml 181 184 181 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 191 200 191 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002338-g003">Figure 3B</xref>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
In addition, immunofluorescence microscopy was performed on cryofrozen longitudinal sections of bone marrow to see if the localization of CXCL12 was different between WT and PECAM-1-/- mice. Figure 3B shows representative images of sections stained for CXCL12, using endoglin (CD105) as a vascular marker, and VCAM (CD106) as a stromal cell marker. Confocal microscopy gave similar results to the ELISA data, with no clear difference in levels or spatial localization of CXCL12. There was no significant difference in VCAM expression or localization. This implies that CXCL12 expression and localization in the bone marrow vascular niche is broadly similar, compared to WT littermates.
###end p 50
###begin p 51
###xml 100 103 100 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Heissig1">[2]</xref>
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Nelissen1">[35]</xref>
###xml 287 290 287 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 301 305 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Enciso1">[36]</xref>
###xml 314 317 314 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 402 411 402 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002338-g003">Figure 3C</xref>
###xml 449 452 449 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Functional levels of MMP-9, a protease which is important in HSC homeostasis and release from the BM[2], were quantified using in gel zymography. MMP-9 has been previously shown to be associated with PECAM-1 activation[35], and other MMPs have been found to be increased in other PECAM-1-/- cell types[36]. PECAM-1-/- bone marrow had significantly increased levels of MMP-9 compared to WT littermates (Figure 3C), suggesting that the loss of PECAM-1-/- in the bone marrow might contribute to the defects we observed.
###end p 51
###begin title 52
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 60 67 60 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
HSC accumulation in the peripheral blood of PECAM-1-/- mice in vivo is due to factors intrinsic to HSC progenitor cell migration as well as blood vessel function
###end title 52
###begin p 53
###xml 85 88 85 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 361 365 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Mazo1">[24]</xref>
###xml 551 560 551 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002338-g004">Figure 4A</xref>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
In order to determine whether the increase in HSC progenitors in the blood of PECAM-1-/- mice could be explained by a defect in the ability of these cells to adhere and migrate between the blood compartment and the bone marrow vasculature, we used an intra-vital skull window model to directly observe progenitor cells interacting with bone marrow blood vessels[24]. Bone marrow cells were fluorescently labelled with CFSE and injected into the carotid artery. Bone marrow blood vessels were identified by pre-administration of FITC labelled albumin (Figure 4A). Representative images show CFSE labelled cells adhering to the smaller sinusoidal vessels in the skull; regions which are thought to be similar to those in the bone marrow. The cells imaged are located on the luminal surface of the endothelial cells, having been captured and tethered from flow.
###end p 53
###begin title 54
###xml 15 18 15 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Loss of PECAM-1-/- on either HSCs or endothelium affects cell adhesion to the bone marrow vasculature.
###end title 54
###begin p 55
###xml 77 81 <span type="species:ncbi:10090">mice</span>
CFSE labelled bone marrow cells from littermates were infused into recipient mice through a canulae in the carotid artery. Vessels in the skull were visualised with an infusion of fluorescine dye, selected fields recorded for 5 mins, and then images collected over the entire exposed vasculature 60 mins post injection. (A) Representative images of fields of view captured. (B) The number of cells adherent to the bone marrow microvessels 60 mins post injection in the exposed left frontoparietal area was quantified. Data shown is the mean+/-S.D of at least three independent experiments per condition, but was not statistically significant using ANOVA analysis.
###end p 55
###begin p 56
###xml 96 105 96 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002338-g004">Figure 4B</xref>
###xml 198 201 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 763 766 763 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 814 817 814 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 818 822 <span type="species:ncbi:10090">mice</span>
One hour post injection, the number of cells adherent to the visualised vessels was quantified (Figure 4B). Using various combinations of host animals with donor cells, we observed that both PECAM-1-/- and WT cells could adhere directly to bone marrow vessels. However genetic deletion of PECAM-1 on transferred cells or recipient bone marrow lead to an increase in the number of cells accumulating on blood vessels in the bone marrow vasculature. Although not statistically significant, this suggests that deletion of PECAM-1 from either the host vasculature or donor HSC results in a delay in the ability of the bone marrow cells to cross endothelium as measured by their increased adherence to the bone marrow lumen. A similar observation was made when PECAM-1-/- bone marrow cells were transferred into PECAM-1-/- mice, suggesting that deletion of PECAM-1 on either the bone marrow precursor cells or the vasculature is sufficient to lead to observed phenotype, consistent with loss of homophilic interactions between PECAM-1 expressed on HSC and the bone marrow vasculature.
###end p 56
###begin title 57
Discussion
###end title 57
###begin p 58
In order to move between the bone marrow and blood compartments, bone marrow progenitor cells have to migrate across vascular cells, which permit the bidirectional movement of haematopoietic cells between these two compartments. Although PECAM-1, expressed on blood and vascular cells has been shown to play an important role in regulating the movement of leucocyte subsets into peripheral tissues, it has remained unclear whether PECAM-1 plays a similar role in regulating progenitor cell migration across the bone marrow vasculature. In this study we describe a novel role for PECAM-1 in regulating progenitor cell numbers in the peripheral blood and show that part of the mechanism by which this occurs is via the effect on CXCL12 dependent HSC migration as well as an increase in MMP-9 expression upon deletion of PECAM-1 on bone marrow vascular cells.
###end p 58
###begin p 59
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Wu1">[21]</xref>
###xml 340 343 340 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 414 417 414 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 717 722 713 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 722 726 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Wu1">[21]</xref>
###xml 977 981 973 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Geiger1">[37]</xref>
###xml 983 987 979 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-deHaan1">[38]</xref>
###xml 1037 1043 1033 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1043 1047 1039 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Wu1">[21]</xref>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 788 792 <span type="species:ncbi:10090">mice</span>
Our data demonstrates that loss of PECAM-1 does not affect the homeostatic balance of HSCs in the bone marrow, resulting in equivalent numbers of both KSL and total mature cells of all lineages. These observations are at odds with those reported by Wu et al[21], who observed a statistically significant hyper cellular marrow in the PECAM-1-/- mice. While we did observe a wider range of KSL numbers in the PECAM-1-/- mice this was not significantly different to WT mice. Further analysis of our data showed that six pairs of mice pairs had less KSL cells defined as KO bone marrow having </=0.9 fold of WT KSL numbers. Nine pairs had more KSL cells defined as KO bone marrow having >/=1.1 fold of WT KSL numbers. Wu et al[21], examined an expanded KSL population based on three pairs of mice. Several studies have reported that intrinsic natural variation between animals warrants the use of substantial animal numbers when comparing stem cell numbers between littermate pairs[37], [38]. The differences between our data and that of Wu et al.[21] may reflect the size of animal groups being used in each study.
###end p 59
###begin p 60
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 504 508 504 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Avecilla1">[39]</xref>
###xml 510 514 510 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Kopp1">[40]</xref>
###xml 691 695 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Petit1">[23]</xref>
###xml 890 894 890 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Yang1">[41]</xref>
###xml 964 967 964 967 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1045 1054 1045 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002338-g003">Figure 3A</xref>
###xml 1110 1113 1110 1113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1155 1164 1155 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002338-g003">Figure 3C</xref>
###xml 1250 1251 1250 1251 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1276 1280 1276 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-McQuibban1">[42]</xref>
###xml 1355 1358 1355 1358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 968 972 <span type="species:ncbi:10090">mice</span>
###xml 1114 1118 <span type="species:ncbi:10090">mice</span>
Our data demonstrates that PECAM-1-/- HSCs have a reduced ability to respond to CXCL12 gradients, which results physiologically in an increased number of progenitors in the peripheral circulation. CXCL12 gradients are crucially important in regulating HSC biology in both the osteoblastic and vascular niches of the bone marrow. CXCL12 produced by osteoblasts is thought to not only provide survival, adhesive and proliferation signals, but is also used in the re-homing of HSCs to the osteoblastic niche[39], [40]. G-CSF induced mobilisation of HSCs results in a dramatic reduction of CXCL12 produced by osteoblasts, thus losing the retention signal required to keep them in the bone marrow[23]. The signalling mechanisms that underpin these CXCL12 mediated effects are still to be elucidated but the Rho GTPases, Rac1 and Rac2 has been shown to be required for HSC mobilisation and homing[41].We have no direct evidence that the osteoblastic niche in the PECAM-1-/- mice is abnormal, as normal levels of CXCL12 are present in the bone marrow (Figure 3A). We have however noted that the bone marrow of PECAM-1-/- mice contains increased levels of MMP-9 (Figure 3C), a proteolytic enzyme which is known to inactivate CXCL12 through cleavage of its NH2-terminal signal sequence[42]. Thus the increase in HSC mobilisation in the resting state of the PECAM-1-/- could be explained by deactivation of exogenous CXCL12 by the excess MMP-9 present in the bone marrow, or protease cleavage of other retention factors such as SCF, resulting in increased mobilization from the bone marrow under steady state conditions.
###end p 60
###begin p 61
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Mazo1">[24]</xref>
###xml 486 489 486 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 606 613 606 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in-vivo</italic>
###xml 490 495 <span type="species:ncbi:10090">mouse</span>
Using intra vital microscopy we have found that PECAM-1 is involved in the migration of bone marrow progenitors from the blood to the bone marrow. We observed an increase in the number of cells binding to the lumen of smaller sinusoidal vessels in the skull when PECAM-1 is deleted from either the endothelium or adoptively transferred cells. These vessels have been previously demonstrated to be physiologically similar to the bone marrow vasculature[24], and suggests that the PECAM-1-/- mouse has a general defect in the ability of cells to interact with both the peripheral and bone marrow vasculature in-vivo. This observation provides an alternative explanation as to the increase in HSC numbers in the peripheral blood, as these cells may have a reduced ability to traffic into the bone marrow or other tissues, resulting in an accumulation in the peripheral blood. Unfortunately our intravital studies are limited to using whole bone marrow isolates, as it was not feasible to look at the trafficking of purified HSCs using this technique due to the small numbers of cells that can be isolated and enriched from the bone marrow.
###end p 61
###begin p 62
###xml 106 110 106 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Katayama1">[43]</xref>
###xml 319 323 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Papayannopoulou1">[44]</xref>
###xml 336 339 333 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 625 628 622 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 705 713 702 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 794 797 791 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 878 882 875 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Graesser1">[45]</xref>
###xml 883 887 880 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Wong1">[47]</xref>
###xml 798 802 <span type="species:ncbi:10090">mice</span>
In the vascular niche, CXCL12 can induce transmigration of HSCs across endothelium, in a P- and E-selectin[43] dependant process. Integrins are also important as induced deletion of either CD29 (beta1 integrin), CD49d (VLA-4) or ligands such as VCAM-1 results in increased numbers of progenitor cells in the circulation[44]. The PECAM-1-/- phenotype resembles elements of these deletion studies which also have increased number of circulating progenitor cells, suggesting that alternative adhesion molecules can compensate in the absence of PECAM-1 expression. We have not observed any significant differences between PECAM-1-/- and WT cells in their ability to adhere or roll on selectin coated surfaces in vitro (data not shown). However, as reported in many other studies, challenged PECAM-1-/- mice demonstrate an inflammatory response which is more aggressive and prolonged[45]-[47]. Our results suggest that part of these differences may occur because of the defect in HSC migration between the blood and BM compartments,
###end p 62
###begin p 63
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 355 359 355 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Newman2">[48]</xref>
###xml 583 587 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Sagawa1">[49]</xref>
###xml 588 592 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Ilan2">[54]</xref>
###xml 706 710 706 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Reedquist1">[57]</xref>
###xml 782 786 782 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Luu1">[55]</xref>
###xml 788 792 788 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Rainger1">[56]</xref>
###xml 1060 1064 1060 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002338-Yang1">[41]</xref>
It is likely that the reduced ability of PECAM-1-/- HSCs to migrate to CXCL12 is due to loss of an intrinsic signalling pathway mediated by the cytoplasmic domain of PECAM-1. The PECAM-1 cytoplasmic domain contains two conserved ITIM domains, and studies have demonstrated that PECAM-1 can have both inhibitory and activatory effects in various cell types[48]. It has been postulated that PECAM-1 can act as a "relay post" for modulating other surface receptors through sequestration of cytoplasmic signalling molecules such as catenins, SHP-1 and SHP-2, Src family kinases and STATs[49]-[54]. PECAM-1 activation can modulate integrin function in leucocytes, by selectively activating the small GTPase Rap1[57], which may be important for PECAM-1 mediated increase in cell migration[55], [56]. The exact signalling pathway utilised by PECAM-1 is yet to be fully described in any cell type studied, including HSCs. However, signalling intermediates known to be activated by PECAM-1, such as Rap1, have already been reported to modulate integrin function in HSCs[41].
###end p 63
###begin p 64
###xml 698 701 698 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 783 786 783 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 702 706 <span type="species:ncbi:10090">mice</span>
###xml 787 791 <span type="species:ncbi:10090">mice</span>
Our study has revealed a novel role for PECAM-1 in the biology of HSCs in the bone marrow and their ability to respond to a CXCL12 gradient, which we propose results in an increased number of progenitor cells in the peripheral circulation. Using in-vivo imaging, we have observed a reduced ability of cells to migrate across bone marrow vascular endothelium upon PECAM-1 deletion. We could find no significant difference in numbers of HSCs or cells derived from them in the bone marrow suggesting that loss of PECAM-1 does not affect hematopoietic homeostatic mechanisms in the bone marrow compartment in the resting state. We have however found higher levels of MMP-9 in the bone marrow of PECAM-1-/- mice suggesting that the vascular niche in the bone marrow is abnormal in PECAM-1-/- mice. These findings further support a role for PECAM-1 in modulating cellular migration and adhesion and extend the vascular compartments regulated by PECAM-1 to include the bone marrow vasculature niche.
###end p 64
###begin p 65
We would like to thank Dr Rudi Manz for his assistance in preparing bone marrow sections, and Dr Paloma Garcia and Miss Mary Clarke for their advice and support.
###end p 65
###begin title 66
References
###end title 66
###begin article-title 67
Changes in integrin expression are associated with altered homing properties of Lin(-/lo)Thy1.1(lo)Sca-1(+)c-kit(+) hematopoietic stem cells following mobilization by cyclophosphamide/granulocyte colony-stimulating factor.
###end article-title 67
###begin article-title 68
Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand.
###end article-title 68
###begin article-title 69
Hematopoietic stem cells are uniquely selective in their migratory response to chemokines.
###end article-title 69
###begin article-title 70
AMD3100 and CD26 Modulate Mobilization, Engraftment, and Survival of Hematopoietic Stem and Progenitor Cells Mediated by the SDF-1/CXCL12-CXCR4 Axis.
###end article-title 70
###begin article-title 71
The regulation of hematopoietic stem cell and progenitor mobilization by chemokine SDF-1.
###end article-title 71
###begin article-title 72
Focal adhesion kinase is required for CXCL12-induced chemotactic and pro-adhesive responses in hematopoietic precursor cells.
###end article-title 72
###begin article-title 73
###xml 80 85 <span type="species:ncbi:9606">human</span>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice.
###end article-title 73
###begin article-title 74
Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches.
###end article-title 74
###begin article-title 75
The biology of PECAM-1.
###end article-title 75
###begin article-title 76
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
ER-MP12 antigen, a new cell surface marker on mouse bone marrow cells with thymus-repopulating ability: I. Intrathymic repopulating ability of ER-MP12-positive bone marrow cells.
###end article-title 76
###begin article-title 77
The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes.
###end article-title 77
###begin article-title 78
###xml 9 14 <span type="species:ncbi:10090">mouse</span>
Distinct mouse bone marrow macrophage precursors identified by differential expression of ER-MP12 and ER-MP20 antigens.
###end article-title 78
###begin article-title 79
Structural identification of the hematopoietic progenitor antigen ER-MP12 as the vascular endothelial adhesion molecule PECAM-1 (CD31).
###end article-title 79
###begin article-title 80
Mobilization kinetics of CD34(+) cells in association with modulation of CD44 and CD31 expression during continuous intravenous administration of G-CSF in normal donors.
###end article-title 80
###begin article-title 81
Transendothelial migration leads to protection from starvation-induced apoptosis in CD34+CD14+ circulating precursors: evidence for PECAM-1 involvement through Akt/PKB activation.
###end article-title 81
###begin article-title 82
Homophilic PECAM-1(CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration.
###end article-title 82
###begin article-title 83
###xml 126 131 <span type="species:ncbi:9606">human</span>
Signals from platelet/endothelial cell adhesion molecule enhance the adhesive activity of the very late antigen-4 integrin of human CD34+ hemopoietic progenitor cells.
###end article-title 83
###begin article-title 84
Transmigration of CD34+ cells across specialized and nonspecialized endothelium requires prior activation by growth factors and is mediated by PECAM-1 (CD31).
###end article-title 84
###begin article-title 85
###xml 61 66 <span type="species:ncbi:9606">human</span>
Adhesion molecules involved in transendothelial migration of human hematopoietic progenitor cells.
###end article-title 85
###begin article-title 86
###xml 101 105 <span type="species:ncbi:10090">mice</span>
A novel role for PECAM-1 in megakaryocytokinesis and recovery of platelet counts in thrombocytopenic mice.
###end article-title 86
###begin article-title 87
PECAM-1: A multifaceted regulator of megakaryocytopoiesis.
###end article-title 87
###begin article-title 88
A new direct-viewing chemotaxis chamber.
###end article-title 88
###begin article-title 89
G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.
###end article-title 89
###begin article-title 90
Adhesion and homing of blood-borne cells in bone marrow microvessels.
###end article-title 90
###begin article-title 91
Matrix metalloproteases: degradation of the inhibitory environment of the transected optic nerve and the scar by regenerating axons.
###end article-title 91
###begin article-title 92
###xml 39 45 <span type="species:ncbi:10090">murine</span>
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
###end article-title 92
###begin article-title 93
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages.
###end article-title 93
###begin article-title 94
Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations.
###end article-title 94
###begin article-title 95
Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells.
###end article-title 95
###begin article-title 96
SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells.
###end article-title 96
###begin article-title 97
###xml 76 82 <span type="species:ncbi:10090">murine</span>
Immunofluorescence characterization of key extracellular matrix proteins in murine bone marrow in situ.
###end article-title 97
###begin article-title 98
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
A monoclonal antibody against an activation epitope on mouse integrin chain beta 1 blocks adhesion of lymphocytes to the endothelial integrin alpha 6 beta 1.
###end article-title 98
###begin article-title 99
Monoclonal antibody 9EG7 defines a novel beta 1 integrin epitope induced by soluble ligand and manganese, but inhibited by calcium.
###end article-title 99
###begin article-title 100
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Soluble c-kit receptor mobilizes hematopoietic stem cells to peripheral blood in mice.
###end article-title 100
###begin article-title 101
###xml 30 35 <span type="species:ncbi:9606">human</span>
Regulation of gelatinase B in human monocytic and endothelial cells by PECAM-1 ligation and its modulation by interferon-beta.
###end article-title 101
###begin article-title 102
Elevated glucose inhibits VEGF-A-mediated endocardial cushion formation: modulation by PECAM-1 and MMP-2.
###end article-title 102
###begin article-title 103
Age- and stage-specific regulation patterns in the hematopoietic stem cell hierarchy.
###end article-title 103
###begin article-title 104
A genetic and genomic analysis identifies a cluster of genes associated with hematopoietic cell turnover.
###end article-title 104
###begin article-title 105
Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis.
###end article-title 105
###begin article-title 106
The bone marrow vascular niche: home of HSC differentiation and mobilization.
###end article-title 106
###begin article-title 107
Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization.
###end article-title 107
###begin article-title 108
Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1.
###end article-title 108
###begin article-title 109
PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and alpha4 integrin.
###end article-title 109
###begin article-title 110
Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization.
###end article-title 110
###begin article-title 111
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice.
###end article-title 111
###begin article-title 112
Endothelial cell PECAM-1 confers protection against endotoxic shock.
###end article-title 112
###begin article-title 113
The inhibitory co-receptor, PECAM-1 provides a protective effect in suppression of collagen-induced arthritis.
###end article-title 113
###begin article-title 114
Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology.
###end article-title 114
###begin article-title 115
The protein-tyrosine phosphatase SHP-2 associates with tyrosine-phosphorylated adhesion molecule PECAM-1 (CD31).
###end article-title 115
###begin article-title 116
Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-gamma1 with PECAM-1/CD31.
###end article-title 116
###begin article-title 117
The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation. Evidence for a mechanistic link between PECAM-1- and integrin-mediated cellular signaling.
###end article-title 117
###begin article-title 118
###xml 68 73 <span type="species:ncbi:9606">human</span>
Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). Identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates.
###end article-title 118
###begin article-title 119
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
Pecam-1 is a modulator of stat family member phosphorylation and localization: lessons from a transgenic mouse.
###end article-title 119
###begin article-title 120
PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics.
###end article-title 120
###begin article-title 121
CD31 regulates direction and rate of neutrophil migration over and under endothelial cells.
###end article-title 121
###begin article-title 122
Cross-talk between cell adhesion molecules regulates the migration velocity of neutrophils.
###end article-title 122
###begin article-title 123
The small GTPase, Rap1, mediates CD31-induced integrin adhesion.
###end article-title 123
###begin p 124
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 124
###begin p 125
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was funded by grants from the Leukaemia Research Fund and Arthritis Research Campaign.
###end p 125

